eCFR Reference Browser

---

title: "21 CFR §530.40"

source: "https://www.ecfr.gov/current/title-21/section-530.40"

title_number: "21"

volume_number: "6"

chapter_number: "Unknown"

subchapter_code: "E"

subchapter_subject: "ANIMAL DRUGS, FEEDS, AND RELATED PRODUCTS"

part_code: "530"

part_subject: "EXTRALABEL DRUG USE IN ANIMALS"

subpart_code: "E"

subpart_subject: "Safe Levels for Extralabel Use of Drugs in Animals and Drugs Prohibited From Extralabel Use in Animals"

section_number: "530.40"

section_subject: "Safe levels and availability of analytical methods."

cfr_reference: "21 CFR 530.40"

title_name: "Title 21"

title_subject: "Food and Drugs"

parts_covered: "Parts 500 to 599"

revised_date: "Revised as of April 1, 2019"

publication_date: "As of April 1, 2019"

contains_description: "Containing a codification of documents of general applicability and future effect"

publication_info: "Published by the Office of the Federal Register National Archives and Records Administration as a Special Edition of the Federal Register"

---

(a)In accordance with § 530.22, the following safe levels for extralabel use of an approved animal drug or human drug have been established: [Reserved]

(b)In accordance with § 530.22, the following analytical methods have been accepted by FDA: [Reserved]

§530.40 - Safe levels and availability of analytical methods.